TransEnterix CEO steps down amid company's financial struggles

The CEO of a Triangle bio-tech firm is stepping down as the company continues to look for ways to finance its operations beyond the first quarter of next year. Research Triangle Park-based TransEnterix (NYSE: TRXC) has announced its long-time president and CEO – Todd Pope – is stepping down effective immediately. According to a company statement, Pope will remain on as a "senior advisor to the company." Pope served as CEO since 2008. His base sa lary in 2018 was $480,800, according to the…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news